EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSOCUG00000007519
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSOCUG00000016192
Gene Symbol: CYSLTR1
2 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSOCUG00000016246
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 3a6

Ensembl ID : ENSOCUG00000023380
Gene Symbol: CYP3A6
3 Cross references
695 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSOCUG00000017790
Gene Symbol: CYP17A1
2 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSOCUG00000000178
Gene Symbol: CYP26A1
3 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSOCUG00000027965
Gene Symbol: CYP46A1
2 Cross references
259 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1

Ensembl ID : ENSOCUG00000012303
Gene Symbol: CYP19A1
4 Cross references
315 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSOCUG00000009053
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSOCUG00000008610
Gene Symbol: DPYD
3 Cross references
220 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSOCUG00000011443
Gene Symbol: DDR2
2 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSOCUG00000004825
Gene Symbol: DRD1
3 Cross references
261 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).